Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.40 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.40 |
| ▸ | ATXN2 | Q99700 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | AKT1 | P31749 | 1/20 | 0.39 |
| ▸ | RXRA | P19793 | 1/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6235042 | 0.86 | MEN1 (0.62) | MEN1KMT2ANPSR1PTGDR2GRIN2B | |
| SCHEMBL542687 | 0.76 | EPHX2 (0.45) | MEN1KMT2ANPSR1PTGDR2ENPP2 | |
| SCHEMBL6236300 | 0.76 | ENPP2 (0.50) | MEN1KMT2ANPSR1AKR1C3ENPP2 | |
| SCHEMBL5366919 | 0.75 | ENPP2 (0.46) | MEN1KMT2AGRIN2BENPP2ATXN2 | |
| SCHEMBL14425369 | 0.75 | ENPP2 (0.46) | MEN1KMT2AGRIN2BENPP2ATXN2 | |
| SCHEMBL27558056 | 0.74 | CYP3A4 (0.48) | — | |
| SCHEMBL542986 | 0.74 | NPSR1 (0.44) | MEN1KMT2ANPSR1PTGDR2ENPP2 | |
| SCHEMBL6236015 | 0.73 | MEN1 (0.62) | MEN1KMT2ANPSR1TSHRENPP2 | |
| SCHEMBL14095609 | 0.73 | KMT2A (0.97) | MEN1KMT2ANPSR1GRIN2BTSHR | |
| SCHEMBL1337663 | 0.73 | KMT2A (0.97) | MEN1KMT2ANPSR1GRIN2BTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1390034-A4 | N-SUBSTITUTED NONARYL-HETEROCYCLO AMIDYL NMDA/NR2B ANTAGONISTS | MERCK & CO INC (US) | 2005-07-13 | — | — | EP | disclosed |
| EP-1390034-A1 | N-SUBSTITUTED NONARYL-HETEROCYCLO AMIDYL NMDA/NR2B ANTAGONISTS | Merck & Co., Inc. (US) | 2004-02-25 | — | — | EP | disclosed |
| WO-2002080928-A1 | N-SUBSTITUTED NONARYL-HETEROCYCLO AMIDYL NMDA/NR2B ANTAGONISTS | MERCK & CO., INC. (US) | 2002-10-17 | — | — | WO | disclosed |